The present study investigated the effect of nitric oxide (NO) on the lifespan of the corpus luteum (CL). Using a competitive nitric oxide synthase (NOS) inhibitor, L-nitro arginine methyl ester (L-NAME, 600 µmol/l), and a longlife NO donor, diethyl-aminetriamine (DETA-NONOate, 10 -8 , 10 -6 or 10 -4 mol/l), we found that in ovaries from rats at the mid stage of CL development, endogenous NO increased both glutathione (GSH) and progesterone production. However, during prostaglandin F 2α (PGF 2α )-induced luteolysis NO acted as an intermediary molecule in the inhibitory effect of PGF 2α , on GSH content. This was supported by the fact that in-vivo PGF 2α treatment enhanced nitric oxide synthase (NOS) activity. These results indicate that the NO could act with a dual action (protective or pro-oxidant) in CL development.
Introduction
, NOS inhibitors block human chorionic gonadotrophin (HCG)-induced ovulation in the rat (Shukovski and Luteal regression or luteolysis is an example of a decrease in Tsafiri, 1994) , endogenously produced NO and NO-releasing cell function, which is a normal and necessary event in the agents have been shown to inhibit steroidogenesis in granulosa mammalian reproductive cycle. This mechanism is widely and luteal cells in both rat and human (Van Voorhis et al., studied for its implication in early pregnancy dysfunction.
1994; Olson et al., 1996) . Recently, the opposite action of the Corpus luteum (CL) involution has been related to an NOS substrate, L-arginine, and HCG on human CL viability increased generation of reactive oxygen species (ROS), e.g. (Vega et al., 2000) has been described. Some authors have O 2 -and H 2 O 2 by the intact ovary (Behrman and Preston, 1989;  pointed out that NO augments oxidative stress-mediated Riley and Behrman, 1991; Sawada and Carlson, 1991) . One toxicity, yet in some cases, NO has been shown to protect consequence of the production of free radicals in ovarian tissue cells from the cytotoxicity of oxidants (Hogg et al., 1995 ; is lipid peroxidation (Kappus, 1985) , which occurs within the Wink et al., 1995) . plasma membrane of luteal cells and may be associated with GSH is a tripeptide thiol present in animal and plant cells. the observed loss of gonadotrophin receptors, diminished cyclic It participates in many cellular functions, including DNA and AMP formation and, therefore, with a decrease in steroidogenic protein synthesis, regulation of enzyme activity, both interability of the CL during involution (Auletta and Flint, 1988;  and intracellular transport, and acts as a major antioxidant in Wang et al., 1991) . Protection against ROS in cells is provided cellular protection (Deneke and Fanburg, 1989) . by enzymes (superoxide dismutase, catalase and gluthation
The relationship between GSH and toxicity mediated by peroxidase), metabolites, e.g. glutathione (GSH) or antioxidant NO has been investigated by other authors. NO has been vitamins (Aten et al., 1992) , and has been suggested to be shown to react with intracellular GSH to form S-nitrosoglutaendocrine-regulated (Laloraya et al., 1988; Aten et al., 1992;  thione (Clancy et al., 1994) ; NO induces oxidative stress and Sugino et al., 1993 Sugino et al., , 1998 Sugino et al., , 1999 .
gluthatione metabolism in rodent and human cells (Luperchio Nitric oxide (NO) has been shown to participate in numerous et al., 1996) , regulates GSH synthesis in bovine aortic physiological processes which are essential for maintaining endothelial cells (Moellering et al., 1999) and stimulates homeostasis (Ignarro, 1990; Moncada et al., 1991) . Some cystein (limiting factor in GSH synthesis) uptake by bovine evidence supports the involvement of NO in ovarian physiendothelial cells . ology; nitrates are secreted from mammalian ovarian disperIn previous studies of the mechanism of CL regression, we sates (Ellman et al., 1993) , NO synthase (NOS) has been reported that oxytocin increased ovarian PGF 2α production during the late phase of pseudopregnancy in rats (Motta et al., located in granulosa cells by immunocytochemistry (Zackrisson phosphate buffer for 1 h in a Dubnoff metabolic shaker under an 1996). This action was mediated by enhancing ovarian NOS atmosphere of 5% CO 2 in 95% O 2 at 37°C. At the end of the activity (Motta et al., 1997) . We also found that during the incubation period, tissues were removed and media collected luteolytic process, endogenous NO increased PGF 2α synthesis for GSH determination. In treated samples a competitive NOS (Motta and Gimeno, 1997) . By means of intrabursa ovarian inhibitor, L-nitro-arginine methyl ester (L-NAME, 600 µmol/l) was sac treatment with two competitive NOS inhibitors and a NO added to the incubation media. We have previously found that generator, we demonstrated that NO produced locally had 600 µmol/l of L-NAME (EC 50 ) inhibits NOS activity in ovarian tissue an antisteroidogenic effect, diminishing serum progesterone (Motta and Gimeno, 1997) . Samples were then incubated with concentrations and increasing ovarian PGF 2α production NADPH, glutathione reductase (GR) and Ellman's reagent (a sulphyd- (Motta et al., 1999) . However, at the mid stage of CL ryl reagent: 5,5Ј-dithiobis-2-nitrobenzoic acid) yielding a chromophdevelopment, ovarian NOS activity was unexpectedly found oric product with a molar absorption at 412 nm. Results are expressed as µmol GSH/g ovarian tissue.
to be higher than during regression (Motta and Gimeno, 1997) 
Materials and methods
previously (Salter et al., 1991) . Briefly, the frozen tissue was homogenized at 0°C in three volumes of 50 mmol/l HEPES, 1 mmol/l DLAnimals dithiothreitol, 1 mmol/l NADPH (pH 7.5) and L-valine (50 mmol/l). The animal model used was the same as that described previously Samples were incubated at 37°C for 15 min with 10 µmol/l [ 14 C] (Lahav et al., 1989) . Briefly, immature (28-30 days) female rats of arginine (0.3 µCi; 1 Ci ϭ 37 GBq). The samples were then applied the Wistar strain were given 15 IU/rat of pregnant mare's serum to 1 ml DOWEX AG50W-X8 (Na ϩ form; Biorad, USA) resin. The gonadotrophin (PMSG; Sigma Chemical Co, St Louis, MO, USA). radioactivity was measured by liquid scintillation counting. Results We considered day 0 of pseudopregnancy to be 48 h post-injection.
were expressed as pmol/g/min. This procedure induced formation of CL that remained functional for 9 Ϯ 1 days (as determined by progesterone radioimmunoassay). The Statistical analysis rats were housed under conditions of controlled temperature (22°C)
Statistical analyses was carried out using the Instat program and illumination (14 h light:10 h dark, lights on at 05:00) and allowed (GraphPAD software, San Diego, CA, USA). Analysis of variance free access to Purina rat chow and water ad libitum. Animals were and Student-Newman-Keuls tests were used for comparisons between anaesthetized with ether and killed by cervical dislocation. As in value of groups. P Ͻ 0.05 was considered to be significant. previous studies (Motta et al., 1996) , ovarian tissues from rats at the mid stage of CL development (day 5 of pseudopregnancy, with highest serum progesterone concentrations) were used.
Results

NO produced by ovarian tissue enhances ovarian glutathione
Experimental protocol concentrations PGF 2α -induced luteolysis For PGF 2α -induced luteolysis, the experimental protocol used was We incubated ovaries from rats at the mid stage of pseudothe same (dose and time) as that described previously (Motta et al., pregnancy (day 5) with the competitive NOS inhibitor, L-1999). Rats were injected i.p. with 3 mg/kg body weight of a synthetic NAME. L-NAME significantly inhibited total GSH production PGF 2α (ILIREN, Hoerscht Vet) in 0.5 ml of saline solution. After (Figure 1a) . In contrast, a long half-life NO donor (DETA-2 h, animals were anaesthetized with ether and killed by cervical NONOate) significantly enhanced ovarian GSH concentrations dislocation. Ovaries were rapidly removed for culture assays or held only at 10 -6 mol/l (Figure 1b) . There was no effect at higher on ice and frozen until determination of NOS activity.
or lower doses.
Ovarian cultures
Removal of ovarian tissue was performed as previously described NO produced by ovarian tissue enhances ovarian progesterone (Dunnam et al., 1999) . Ovarian tissues were removed and cut into concentrations quarters. They were then randomly and evenly distributed at four
The inhibition of endogenous NO production by 600 µmol/l explants per well in a 24-well culture plate (Nunc multidish, USA) of L-NAME significantly diminished progesterone production for 18 h in an incubator with a humidified chamber and 5% carbon in ovarian tissue from rats at the mid stage of CL development dioxide at 37°C. Separate aliquots of culture media were collected (Figure 2a) . The NO donor, DETA-NONOate at 10 -4 and for GSH and progesterone determination.
10 -6 mol/l, significantly enhanced ovarian progesterone pro-
GSH determination
duction after 18 h of treatment. At the lowest dose of DETA-NONOate used (10 -8 mol/l), no effect on ovarian
The GSH assay was carried out as described previously (Tietze, 1969) . Briefly, ovarian tissues were incubated in Krebs Ringer progesterone production was observed. L-NAME (600 µmol/l) in 1 ml of Krebs Ringer phosphate buffer pseudopregnancy were incubated in 1 ml of Krebs Ringer for 1 h at 37°C. At the end of incubation period, tissues were phosphate buffer for 1 h at 37°C with or without 600 µmol/l of removed and media was collected for GSH determination. (b) L-NAME. (b) Ovarian tissues from rats at the mid stage of Ovarian tissues from rats at the mid stages of pseudopregnancy pseudopregnancy were removed and cut into quarters and randomly were removed and cut into quarters and randomly distributed at distributed at four explants per well in a 24-well culture plate.
four explants per well in a 24-well culture plate. Ovarian explants Ovarian explants were then incubated with or without DETAwere then incubated with or without DETA-NONOate (10 -8 , 10 -6 NONOate (10 -8 , 10 -6 and 10 -4 mol/l) in medium 199 for 18 h in and 10 -4 mol/l) in medium 199 for 18 h in an incubator with a an incubator with a humidified chamber and 5% carbon dioxide at humidified chamber and 5% carbon dioxide at 37°C. At the end of 37°C. At the end of the incubation period, tissues were removed the incubation period, tissues were removed and media was and media was collected for glutathione (GSH) determination. Each collected for glutathione (GSH) determination. Each group group represents the mean Ϯ SEM of 10 different animals.
represents the mean Ϯ SEM of 10 different animals. Experiments Experiments were carried out in duplicate. *Significantly different were carried out in duplicate. *Significantly different from the other from the other groups (P Ͻ 0.05).
groups (P Ͻ 0.05).
PGF 2α diminishes glutathione produced by ovarian tissue: 1991). Following this, many studies were conducted to NO as a possible intermediary metabolite investigate the role of NO in the oxidative stress, both in As previously described (Motta et al., 1999) , we induced pathological and physiological events (Shukovski and Tsafiri, luteolysis with a synthetic PGF 2α . After this procedure GSH 1994; Van Voorhis et al., 1994; Motta et al., 1996 Motta et al., , 1997 . production was diminished compared with that in controls However, the formation of NO can lead to the production of (Figure 3 ). When L-NAME was added during the incubation reactive nitrogen oxide species (RNOS) (Wink et al., 1996) . period, PGF 2α -induced inhibition of ovarian GSH production Like ROS, these NO-derived reactive intermediate species can was completely abolished (Figure 3) . result in damage to specific cellular targets, which leads to speculation that NO may have a significant role in various PGF 2α induces luteolysis by increasing NOS activity pathological conditions (Gross and Wolin, 1995; Wink et al., In order to know whether NO could be an intermediary in the 1996). Recently, this radical gas has been shown to participate action of PGF 2α on GSH depletion during induced luteolysis, in numerous physiological processes which are essential for we determined NOS activity in ovarian homogenates from rats maintaining homeostasis (Ignarro, 1990; Moncada et al., 1991) . injected with PGF 2α 2 h before the determination of NOS Recent reports (Wink et al., 1995; Hogg et al., 1995) have activity. As shown in Figure 4 , NOS activity was significantly pointed out that NO could protect cells from oxidants. enhanced by the in-vivo PGF 2α treatment.
Apparently, the toxic or protective effect of NO appears to be et al., 1999) , while short-lived NO donors produced a cytotoxic effect depleting GSH content. These apparently controversial results could be explained by the fact that an acute exposure of cells to NO donors would lead to depletion of GSH, whereas chronic exposure would result in a progressive increase in cytosolic GSH Moellering et al., 1999; Rosenberg et al., 1999) . In spite of diverse mechanisms being proposed (NO increasing cystine Figure 3 . Effect of L-nitro arginine methyl ester (L-NAME) and uptake, NO inducing γ-glutamylcysteine synthetase and prostaglandin F 2α (PGF 2α ) on glutathione (GSH) production. Ovarian tissues from rats at the mid stage of pseudopregnancy were γ-glutamyl transpeptidase), the activation of a crucial protecincubated with or without L-NAME (600 µmol/l) in 1 ml of Krebs tive factor or inactivation of a crucial death factor in the setting
Ringer Phosphate buffer for 1 h at 37°C. In another group, PGF 2α of oxidative stress is still unknown.
(3 mg/kg weight) was injected i.p. in rats at the mid stage of Using L-NAME to inhibit endogenous NO and a long halfpseudopregnancy to induce luteolysis. After 2 h, ovarian tissue was life NO donor (DETA-NONOate), we found that NO increased removed and incubated with or without L-NAME, as described above. At the end of incubation period, tissues were removed and progesterone production. This result is in agreement with that of , 1999) . However, in contrast, a previous study using rat
ovarian tissue during the late stage of CL development, demonstrated that in-vivo NO generator treatment (sodium nitroprusside) diminished serum concentrations of progesterone (Motta et al., 1999) . Those results led us to conclude that NO can have opposing actions, depending on the stage of CL development. As in the GSH determination experiments, there appears to be a dose-dependent relationship between DETA NONOate and progesterone since 10 -6 and 10 -4 mol/l increased (while 10 -8 mol/l had no effect on) ovarian progesterone production.
As NO was able to increase progesterone production and NONOate) significantly decreased the production of progesterone in human CL cells of the late, but not the mid, luteal phase. In addition, these authors found that NO increased diminished NOS activity with the age of the CL (Motta et al., 1997) , the present study was performed in order to investigate concentrations of both PGF 2α and PGE during the late luteal phase. the possible protective function of endogenous ovarian NO in the early stage of CL development and to compare this role
We also focused our study on the role of NO during luteolysis in order to compare the effect with the abovewith its role during luteolysis.
In the present study, we found that NO produced by ovarian mentioned protective action. In previous reports, we had found that during CL demise, PGF 2α and NO were related by a tissue at the mid stage of CL development increases GSH production, as demonstrated by the fact that the specific NOS positive feedback pathway leading to higher concentrations of lipid peroxidation (Motta et al., 1996) concomitantly with a inhibitor diminished, while a long half-life NO donor increased GSH concentrations. This latter effect was observed at diminution in the progesterone concentrations (Motta et al., 1999) . In this study, we demonstrated that PGF 2α diminishes 10 -6 mol/l concentration of DETA-NONOate, while lower and higher doses had no effect. The failure of the higher dose GSH content, and that this may be mediated by NO. The fact that PGF 2α -treatment increased NOS activity also suggests (10 -4 mol/l) to stimulate GSH production could be the result of down-regulation on the NOS activity by a direct effect of that this action could be NO-dependent. In agreement with our previous report (Motta et al., 1999) , this confirms that as NO (Rengasamy and Johns, 1993) . We believe that, in the early stage of CL development, the chronic exposure of in spontaneous luteolysis, the PGF 2α and NO/NOS system could be related during PGF 2α -induced luteolysis. endogenous NO could be responsible for the increase in the In summary, we propose that during early stages of CL lipid peroxidation (Motta et al., 2000) . It is important to point Motta, A.B. and Gimeno, M.A.F. (1997) Nitric oxide participates in the corpus luteum regression in ovaries isolated from pseudopregnant rats. Can.
out that the GSH metabolite is considered to be an important 
